Hagler Mark Arnold
SEC insider (Form 3/4/5 filer). CIK 0002126029. Chief Commercial Officer at NovaBridge Biosciences (NBP). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in ROCKVILLE, MD.
Companies Hagler Mark Arnold has filed insider reports for
- NovaBridge Biosciences (NBP): Officer, Chief Commercial Officer
Hagler Mark Arnold
CIK: 0002126029
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NBP
NovaBridge Biosciences
Officer